| Mepha Pharma AG - Lacosamid-Mepha 50 mg, Filmtabletten | | 67630 | | 01 | | Lacosamid-Mepha 50 mg | | Filmtabletten | | N03AX18 | | | | 26.06.2021 | | |
| | Composition | | Filmtablette: lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), E 172 (nigrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. | informations additionels |
|---|
| | 50 mg | Filmtablette |
| | BAG: Principe actif | Concentr. |
|---|
| | 50 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | Macrogol | | | | | | | | | | Überzug | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 14 | 4.06 | 13.65 | B | LS | Non |
|
|
